Cancer Medical Professionals
Early-Phase Clinical Trials Program
HOSPITAL
University Hospitals Seidman Cancer Center
KEY CONTACTS
Afshin Dowlati, MD, Director, Center for Cancer Drug Development 216-844-1228, Afshin.Dowlati@UHhospitals.org
APPOINTMENT LINE
Please call Erica Gentile, New Patient Intake Coordinator, at 216-286-2292.
For hospital transfers, please call 216-844-1111.
Conditions Treated
- Any recurrent or refractory cancers
- Any cancer where standard therapy can be improved
Therapies
- New targeted therapies
- Immunotherapy
- Cell therapies
- Cancer vaccines
- Proton beam therapy
Distinguishing Features
- Part of NCI-designated Case Comprehensive Cancer Center
- Dedicated team with specialized expertise in early-phase clinical trials
- Genomic evaluation for optimal selection of studies
- Specialized Adolescent and Young Adult (AYA) cancer program
- Access to new drugs in NCI portfolio as members of NCI Experimental Therapeutic Clinical Trials Network
- Extensive portfolio of Phase I and Phase II treatment studies